A New Biomarker for Acute COVID-19 May Have Been Found in Blood
Researchers at Karolinska Institutet in Sweden completed a study that indicates that increased levels of the cytokine interleukin-26 (IL-26) in blood is a potential biomarker for severe COVID-19.Scientists have shown that patients with acute <span class="glossaryLink" aria-describedby="tt" data-cmtooltip="<div class=glossaryItemTitle>COVID-19</div><div class=glossaryItemBody>First identified in 2019 in Wuhan, China, COVID-19, or Coronavirus disease 2019, (which was originally…